Literature DB >> 24484249

Analysis of 5-aminolevulinic acid-induced fluorescence in 55 different spinal tumors.

Matthias Millesi1, Barbara Kiesel, Adelheid Woehrer, Johannes A Hainfellner, Klaus Novak, Mauricio Martínez-Moreno, Stefan Wolfsberger, Engelbert Knosp, Georg Widhalm.   

Abstract

OBJECT: Subtotal resection (STR) of spinal tumors can result in tumor recurrence. Currently, no clinically reliable marker is available for intraoperative visualization of spinal tumor tissue. Protoporphyrin IX (PpIX) fluorescence induced by 5-aminolevulinic acid (5-ALA) is capable of visualizing malignant gliomas. Fluorescence-guided resections of malignant cerebral gliomas using 5-ALA have resulted in an increased rate of complete tumor removal. Recently, the application of 5-ALA has also been described in the first cases of spinal tumors. Therefore, the aim of this observational study was to systematically investigate 5-ALA-induced fluorescence characteristics in different spinal tumor entities.
METHODS: Three hours before the induction of anesthesia, 5-ALA was administered to patients with different intra- and extradural spinal tumors. In all patients a neurosurgical resection or biopsy of the spinal tumor was performed under conventional white-light microscopy. During each surgery, the presence of PpIX fluorescence was additionally assessed using a modified neurosurgical microscope. At the end of an assumed gross-total resection (GTR) under white-light microscopy, a final inspection of the surgical cavity of fluorescing intramedullary tumors was performed to look for any remaining fluorescing foci. Histopathological tumor diagnosis was established according to the current WHO classification.
RESULTS: Fifty-two patients with 55 spinal tumors were included in this study. Resection was performed in 50 of 55 cases, whereas 5 of 55 cases underwent biopsy. Gross-total resection was achieved in 37 cases, STR in 5, and partial resection in 8 cases. Protoporphyrin IX fluorescence was visible in 30 (55%) of 55 cases, but not in 25 (45%) of 55 cases. Positive PpIX fluorescence was mainly detected in ependymomas (12 of 12), meningiomas (12 of 12), hemangiopericytomas (3 of 3), and in drop metastases of primary CNS tumors (2 of 2). In contrast, none of the neurinomas (8 of 8), carcinoma metastases (5 of 5), and primary spinal gliomas (3 of 3; 1 pilocytic astrocytoma, 1 WHO Grade II astrocytoma, 1 WHO Grade III anaplastic oligoastrocytoma) revealed PpIX fluorescence. It is notable that residual fluorescing tumor foci were detected and subsequently resected in 4 of 8 intramedullary ependymomas despite assumed GTR under white-light microscopy.
CONCLUSIONS: In this study, 5-ALA-PpIX fluorescence was observed in spinal tumors, especially ependymomas, meningiomas, hemangiopericytomas, and drop metastases of primary CNS tumors. In cases of intramedullary tumors, 5-ALA-induced PpIX fluorescence is a useful tool for the detection of potential residual tumor foci.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24484249     DOI: 10.3171/2013.12.FOCUS13485

Source DB:  PubMed          Journal:  Neurosurg Focus        ISSN: 1092-0684            Impact factor:   4.047


  15 in total

1.  Safety and Tumor Specificity of Cetuximab-IRDye800 for Surgical Navigation in Head and Neck Cancer.

Authors:  Eben L Rosenthal; Jason M Warram; Esther de Boer; Thomas K Chung; Melissa L Korb; Margie Brandwein-Gensler; Theresa V Strong; Cecelia E Schmalbach; Anthony B Morlandt; Garima Agarwal; Yolanda E Hartman; William R Carroll; Joshua S Richman; Lisa K Clemons; Lisle M Nabell; Kurt R Zinn
Journal:  Clin Cancer Res       Date:  2015-04-22       Impact factor: 12.531

2.  Quantitative fluorescence using 5-aminolevulinic acid-induced protoporphyrin IX biomarker as a surgical adjunct in low-grade glioma surgery.

Authors:  Pablo A Valdés; Valerie Jacobs; Brent T Harris; Brian C Wilson; Frederic Leblond; Keith D Paulsen; David W Roberts
Journal:  J Neurosurg       Date:  2015-07-03       Impact factor: 5.115

Review 3.  Current Management and Treatment Modalities for Intramedullary Spinal Cord Tumors.

Authors:  Rupa G Juthani; Mark H Bilsky; Michael A Vogelbaum
Journal:  Curr Treat Options Oncol       Date:  2015-08

4.  A ratiometric threshold for determining presence of cancer during fluorescence-guided surgery.

Authors:  Jason M Warram; Esther de Boer; Lindsay S Moore; Cecelia E Schmalbach; Kirk P Withrow; William R Carroll; Joshua S Richman; Anthony B Morlandt; Margaret Brandwein-Gensler; Eben L Rosenthal
Journal:  J Surg Oncol       Date:  2015-06-12       Impact factor: 3.454

5.  Fluorescence-guided resection with 5-aminolevulinic acid of meningeal sarcoma in a child.

Authors:  Luis Miguel Bernal García; José Manuel Cabezudo Artero; Manuel Royano Sánchez; María Bella Marcelo Zamorano; María López Macías
Journal:  Childs Nerv Syst       Date:  2015-04-12       Impact factor: 1.475

Review 6.  Spinal Solitary Fibrous Tumors: An Original Multicenter Series and Systematic Review of Presentation, Management, and Prognosis.

Authors:  Caroline Apra; Amira El Arbi; Anne-Sophie Montero; Fabrice Parker; Steven Knafo
Journal:  Cancers (Basel)       Date:  2022-06-08       Impact factor: 6.575

Review 7.  Various shades of red-a systematic analysis of qualitative estimation of ALA-derived fluorescence in neurosurgery.

Authors:  Marcel A Kamp; Zarela Krause Molle; Christopher Munoz-Bendix; Marion Rapp; Michael Sabel; Hans-Jakob Steiger; Jan F Cornelius
Journal:  Neurosurg Rev       Date:  2016-05-25       Impact factor: 3.042

Review 8.  Combination of Fluorescence-Guided Surgery With Photodynamic Therapy for the Treatment of Cancer.

Authors:  Jun He; Leping Yang; Wenjun Yi; Wentao Fan; Yu Wen; Xiongying Miao; Li Xiong
Journal:  Mol Imaging       Date:  2017 Jan-Dec       Impact factor: 4.488

Review 9.  Fluorescence-Guided Surgery: A Review on Timing and Use in Brain Tumor Surgery.

Authors:  Alexander J Schupper; Manasa Rao; Nicki Mohammadi; Rebecca Baron; John Y K Lee; Francesco Acerbi; Constantinos G Hadjipanayis
Journal:  Front Neurol       Date:  2021-06-16       Impact factor: 4.003

10.  Is Visible Aminolevulinic Acid-Induced Fluorescence an Independent Biomarker for Prognosis in Histologically Confirmed (World Health Organization 2016) Low-Grade Gliomas?

Authors:  Mohammed Jaber; Christian Ewelt; Johannes Wölfer; Benjamin Brokinkel; Christian Thomas; Martin Hasselblatt; Oliver Grauer; Walter Stummer
Journal:  Neurosurgery       Date:  2019-06-01       Impact factor: 4.654

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.